drugset / Trial / NCT06373627

Procedural Pain Management by Multimodal Sedation Analgesia Combining Hypnosis in Children With Congenital Heart Disease

NCT06373627

Unknown 104 enrolled Fondation Hôpital Saint-Joseph
RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of this prospective randomized controlled trial is to evaluate therapeutic hypnosis as a co-analgesia in thoracic drain removal in children with congenital heart disease. The hypothesis of this study is that therapeutic hypnosis combined with a minimal effective dose of medicated and inhaled sedation-analgesia is not inferior to higher doses of sedation-analgesia usually employed. This would make possible the reduction of cumulative dose of sedative medication and their side effects.

Timeline

Start
2024-05-02
Primary completion
2025-05-02
Completion
2025-05-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.3 mg/kg Intravenous
Subject Ketamine Small molecule 0.5 mg/kg Intravenous
Subject Midazolam Small molecule 50 ug/kg Intravenous
Background MEOPA Unknown
Background Medications used in addition to hypnosis Unknown